Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
AbbVie Biotech Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
AbbVie Biotech Ventures

AbbVie Biotech Ventures

Operating

ABVI: A US-based venture capital firm specializing in investments in biotech and pharmaceutical sectors.

Location
Chicago, IL, US
Founded
2009
Firm
Compare
Portfolio
Employees
Website

AbbVie Biotech Ventures Inc. (ABVI) is a US-based venture capital firm specializing in investments in the biotech and pharmaceutical sectors. The firm typically participates in various stages of funding, including Seed, Series A, B, C, D, and E rounds. ABVI's investment focus is on innovative companies that are developing cutting-edge solutions to address significant health challenges.

Notable portfolio companies include Accent Therapeutics, Alector, Caribou Biosciences, and Jnana Therapeutics, among others. ABVI's investment philosophy centers on fostering scientific progress through bold action and innovation. The firm offers unique value-add services to its portfolio companies, leveraging AbbVie's extensive expertise in drug development and commercialization to support their growth and success.

AbbVie Biotech Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments38
Current Portfolio Count23
Total Portfolio Exits1

Top Investment Stages

Series A16 (44.4%)
Series B9 (25.0%)
Series C6 (16.7%)
Seed3 (8.3%)
Series D2 (5.6%)

Stage Mix

Series A 44%Series B 25%Series C 17%Seed 8%Series D 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Accent Therapeutics logo

Accent Therapeutics

Mozart Therapeutics logo

Mozart Therapeutics

Quanta Therapeutics logo

Quanta Therapeutics

Jnana Therapeutics logo

Jnana Therapeutics

Ambagon Therapeutics logo

Ambagon Therapeutics

Nitrase Therapeutics logo

Nitrase Therapeutics

Starday Foods logo

Starday Foods

Stemson Therapeutics logo

Stemson Therapeutics

Ribon Therapeutics logo

Ribon Therapeutics

Caribou Biosciences logo

Caribou Biosciences

Carisma Therapeutics logo

Carisma Therapeutics

Faze Medicines logo

Faze Medicines

Palleon Pharmaceuticals logo

Palleon Pharmaceuticals

Jacobio Pharmaceuticals logo

Jacobio Pharmaceuticals

Quench Bio logo

Quench Bio

Pact Pharma logo

Pact Pharma

Prevail Therapeutics logo

Prevail Therapeutics

Ribometrix logo

Ribometrix

Magnolia Neurosciences logo

Magnolia Neurosciences

Alector logo

Alector

Quentis Therapeutics logo

Quentis Therapeutics

Exicure logo

Exicure

ApoGen Biotechnologies logo

ApoGen Biotechnologies

Morphic Therapeutic logo

Morphic Therapeutic

Avaxia Biologics logo

Avaxia Biologics

AbbVie Biotech Ventures - Similar Investment Firms

Abbott logo

Abbott

abbott.com

Bioventures Investors logo

Bioventures Investors

Avalon BioVentures logo

Avalon BioVentures

Versant Ventures logo

Versant Ventures

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

ABV logo

ABV

abv.com

Vida Ventures logo

Vida Ventures

vidaventures.com

Venture Investors logo

Venture Investors

Alpine BioVentures GP logo

Alpine BioVentures GP

Pfizer Venture Investments logo

Pfizer Venture Investments

pfizer.com

Atlas Venture logo

Atlas Venture

atlasventure.com

Aberdare Ventures logo

Aberdare Ventures

aberdare.com

Inbio Ventures logo

Inbio Ventures

Biotech Insight Ventures logo

Biotech Insight Ventures

Bioluminescence Ventures logo

Bioluminescence Ventures

AbbVie Biotech Ventures - Classification

Also Known As
  • Abbvie Biotech Ventures Inc.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end